AQR Capital Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$166K Sell
13,974
-181,401
-93% -$2.35M ﹤0.01% 3920
2026
Q2
$2.57M Buy
195,375
+68,789
+54% +$1.54M ﹤0.01% 2458
2026
Q1
$3.33M Buy
126,586
+112,595
+805% +$14.2M ﹤0.01% 2015
2025
Q4
$3.47M Buy
13,991
+5,908
+73% +$1.35M ﹤0.01% 1791
2025
Q3
$1.7M Buy
+8,083
New +$1.43M ﹤0.01% 2083
2023
Q1
– Sell
-181
Closed -$31.4K – 2202
2022
Q4
$31.4K Buy
+181
New +$119K ﹤0.01% 2176

Other funds holding GOSS

AQR Capital Management's GOSS Position: Q3 2026 in Review

AQR Capital Management reduced its Gossamer Bio (GOSS) stake by 93% in Q3 2026, selling an estimated $2.35M and leaving 13,974 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #3920.

AQR Capital Management first reported a position in GOSS in Q4 2022 and has held it in 6 quarters since. The position peaked at $3.47M in Q4 2025. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • AQR Capital Management held 13,974 shares of Gossamer Bio worth $166K as of Q3 2026.
  • AQR Capital Management sold 181,401 Gossamer Bio shares in Q3 2026, an estimated $2.35M.
  • Gossamer Bio made up ﹤0.01% of AQR Capital Management's portfolio in Q3 2026, its #3920 holding.
  • AQR Capital Management first reported a position in Gossamer Bio in Q4 2022 and has held it in 6 quarters since.
  • AQR Capital Management's Gossamer Bio position peaked at $3.47M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.